ELDERLY-T: A Non-interventional, Multicentre, Prospective Observational Study on the Effectiveness and Safety of Insulin Glargine 300 U/ml in Elderly Patients ≥75 Years of Age With Type 2 Diabetes
Latest Information Update: 17 Apr 2024
At a glance
- Drugs Insulin glargine (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms ELDERLY-T
- Sponsors Sanofi
- 10 Apr 2024 Status changed from active, no longer recruiting to completed.
- 06 Sep 2023 Planned End Date changed from 16 Nov 2023 to 5 Dec 2023.
- 06 Sep 2023 Planned primary completion date changed from 16 Nov 2023 to 5 Dec 2023.